Phase IAndrogen Modulator
Compound 61500
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061500
Risk Class
LOW
Last Audit
Mar 11, 2108
Research Abstract
Androgen Modulator candidate engineered for metabolic regulation initiatives with automated dossier coverage.
Compound 61500 is a androgen modulator asset inside androgen modulator innovation track initiatives, optimized for metabolic regulation and cardiometabolic recovery.
The dossier currently sits in phase i with a low risk rating, meaning it is cleared for baseline monitoring protocols.
Supply records cite CAS AUTO-061500 with updates logged 2108-03-11.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Metabolic regulationCardiometabolic recovery
Nomenclature
CX-61500Androgen Modulator Program 61500
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061500
- [2] Operations Pulse • Androgen Modulator innovation track
- [3] Risk Governance Ledger • LOW clearance for COMPOUND-61500